Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1b Trial of Lenvatinib Plus Pembrolizumab in Participants With Selected Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Study of TAB08 in Patients With Advanced Solid Neoplasms
- Status
- COMPLETED
- Phase
- PHASE1
Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Ixazomib and Erlotinib in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Kanitinib in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
- Status
- TERMINATED
- Phase
- PHASE1
Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive in Advanced Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of RC48-ADC in Subjects With HER2-Positive Advanced Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
MASCT-I Treatment for Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Prospective Observational Study to Investigate the Added Value of the Health Related Quality of Life and Patient Reported Symptoms in the Identification of the Recommended Phase II Dose in Phase I Trials of Molecularly Targeted Therapies.
- Status
- UNKNOWN
- Phase
- N/A
Study of JS001 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of CD133KDEL Toxin in the Treatment for Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Ceramide NanoLiposome in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Determine the Excretion Balance, Pharmacokinetics, Metabolism and Absolute Oral Bioavailability of a Single Oral Dose of [14C]-Labeled Idasanutlin and an Intravenous Tracer Dose of [13C]-Labeled Idasanutlin in a Single Cohort of Participants With Solid Tumors (Malignancies)
- Status
- COMPLETED
- Phase
- PHASE1